0000886163-20-000029.txt : 20200313 0000886163-20-000029.hdr.sgml : 20200313 20200313183329 ACCESSION NUMBER: 0000886163-20-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200313 FILED AS OF DATE: 20200313 DATE AS OF CHANGE: 20200313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOEHR MATTHEW W CENTRAL INDEX KEY: 0001237556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 20714563 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES RD #200 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-03-13 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001237556 FOEHR MATTHEW W 3911 SORRENTO VALLEY BOULEVARD, STE 110 SAN DIEGO CA 92121 0 1 0 0 President and COO Common Stock 2020-03-13 4 M 0 2000 21.92 A 157449 D Employee Stock Option (right to buy) 21.92 2020-03-13 2020-03-13 4 M 0 2000 0.0 D 2023-02-15 Common Stock 2000 64625 D Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/15/13. By: Charles S. Berkman For: Matthew W. Foehr 2020-03-13